Learning Biology is an evolving process. The science keeps changing towards a greater understanding and sometimes the conclusions that were drawn are not always right. For example, blood letting or bleeding a person used to be the treatment for some diseases. That was an acceptable form of treatment but now we wonder as to what led to those conclusions? It is difficult to be just 100% right all the time. When a scientist makes a specific theory, it is based upon the data that is available at that time. If that data changes over the period or some new information comes in then the theory has to change. As scientists, we beat ourselves up on being right 100% of the time and if that is what we aim for then it would be impossible to conclude anything and we would just want to be quiet and live in a cave without concluding anything. However, the good scientists try’s to find the interesting (which may also vary) things in the world and work on them. There is another catch here: if they work on something that is just “cool” and has a lot of other scientists working on them, then there will be no differentiator. A good scientist will try to discover and work on interesting things to work on that are interesting to them and are cool but is the kind of thing that no one is paying much attention to…
Similar Posts
Biology games
There have been many games that have been developed to enhance the understanding of biology and not many of them are good. However, when they work well – like this example from the Nobel prize foundation that is illustrated below – they illustrate the concept well. One wonders how many of these games illustrate all…
Antifungals
There are several antifungals in the market and it is difficult to understand how many more are needed since there are quite a few in the market. One major use is for treatment of Athelete’s foot. Fungi contain cell wall made up of beta-1-3-glucan, other glucans and gylcoprotein. Below the cell wall there is a…
Molecularly imprinted polymers
This is an approach to design polymers that recognize materials which may be of biological origin. Their advantage is their high selectivity and affinity for the target molecule. The high level view of the process to create such a polymer is relatively simple though the devil may be in the details. In the presence of…
Biomarkers in Inflammatory bowel disease with antibody therapy
Two types of inflammatory bowel disease, Ulcerative colitis and Crohn’s disease. A challenge in IBD development is that many drugs show systemic PK and PD but fail in the intestinal mucosa. Most companies focus on Ulcerative colitis due to a) homogenous biology, b) access to tissue, c) established endpoints and d) lower variability in translational…
Biological forces, picoNewtons and forces at the microscopic level
It is hard to imagine binding forces as a scientist develops an immune-assay and often times the commonly used antibodies are often thought to be the tightest binders. But these forces are very interesting to measure and compare among different types of interactions. But first what is the measurement unit of the force? The force…
Bile duct cancer
Bile duct cancer or cholangiocarcinoma, (CCA) is a rare cancer with an incidence of ~3 cases per 100,000 with 10,000 new case diagnosed annually. It is about 10-20% of liver cancers. Interestingly, in Thailand, and some south east asian countries, the incidence is nearly 10 fold higher due to liver fluke infections (Opisthorchis viverrini and…